Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - FREE CASH FLOW
Free Cash Flow LRMR - Larimar Therapeutics, Inc.
-33.6 M
LAST VALUE
10.99%
2 YEAR CAGR
8.21%
5 YEAR CAGR
-8.39%
10 YEAR CAGR